We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALOG
501
DELISTED
Analogic Corp
ALOG
| $1.18M | 0.02% |
14,334
-6,860
| -32% | -$615K |
|
502
Quantum Corp
QMCO
$437M
| $1.17M | 0.02% |
6,015
+870
| +17% | +$170K |
|
|
SPTN
503
DELISTED
SpartanNash
SPTN
| $1.17M | 0.02% |
50,338
+31,904
| +173% | +$726K |
|
|
TOWR
504
DELISTED
Tower International, Inc.
TOWR
| $1.17M | 0.02% |
42,900
+22,500
| +110% | +$551K |
|
|
PKD
505
DELISTED
Parker Drilling Company
PKD
| $1.17M | 0.02% |
+10,976
| New | +$1.25M |
|
|
BIG
506
DELISTED
Big Lots, Inc.
BIG
| $1.15M | 0.02% |
30,450
-49,570
| -62% | -$1.53M |
|
507
Dine Brands
DIN
$432M
| $1.15M | 0.02% |
+14,729
| New | +$1.19M |
|
|
CBK
508
DELISTED
Christopher & Banks Corporation
CBK
| $1.15M | 0.02% |
174,000
+17,271
| +11% | +$118K |
|
509
Stoneridge
SRI
$209M
| $1.14M | 0.02% |
101,719
+4,800
| +5% | +$54K |
|
510
MaxLinear
MXL
$6.49B
| $1.14M | 0.02% |
120,250
+12,501
| +12% | +$125K |
|
|
DMND
511
DELISTED
DIAMOND FOODS, INC.
DMND
| $1.13M | 0.02% |
+32,370
| New | +$917K |
|
512
Vaalco Energy
EGY
$594M
| $1.13M | 0.02% |
+132,218
| New | +$887K |
|
513
JPMorgan Chase
JPM
$939B
| $1.13M | 0.02% |
18,620
-180,840
| -91% | -$10.5M |
|
514
Columbia Sportswear
COLM
$3.19B
| $1.13M | 0.02% |
+27,304
| New | +$1.09M |
|
515
Teekay Tankers
TNK
$2.63B
| $1.13M | 0.02% |
39,795
+32,200
| +424% | +$1.01M |
|
516
Polaris
PII
$4.15B
| $1.11M | 0.02% |
7,956
-8,590
| -52% | -$1.16M |
|
|
ARGO
517
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.1M | 0.02% |
33,340
+5,705
| +21% | +$185K |
|
|
CVD
518
DELISTED
COVANCE INC.
CVD
| $1.1M | 0.02% |
+10,580
| New | +$1.05M |
|
519
Coca-Cola Consolidated
COKE
$12.3B
| $1.1M | 0.02% |
129,180
-7,500
| -5% | -$57.5K |
|
|
RST
520
DELISTED
ROSETTA STONE INC
RST
| $1.09M | 0.02% |
97,017
+15,900
| +20% | +$183K |
|
521
Pacific Biosciences
PACB
$422M
| $1.09M | 0.02% |
203,284
+77,694
| +62% | +$491K |
|
|
BNY
522
Bank of New York Mellon
BNY
$108B
| $1.08M | 0.02% |
30,560
+18,390
| +151% | +$607K |
|
|
GRA
523
DELISTED
W.R. Grace & Co.
GRA
| $1.08M | 0.02% |
10,860
-47,310
| -81% | -$4.66M |
|
524
Webster Financial
WBS
$12.3B
| $1.07M | 0.02% |
34,490
+18,930
| +122% | +$581K |
|
525
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.07M | 0.02% |
8,560
+610
| +8% | +$71.3K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.